These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 3144532)

  • 41. The effect of milk consumption on the pharmacokinetics of fleroxacin and ciprofloxacin in healthy volunteers.
    Hoogkamer JF; Kleinbloesem CH
    Drugs; 1995; 49 Suppl 2():346-8. PubMed ID: 8549357
    [No Abstract]   [Full Text] [Related]  

  • 42. Overview of the pharmacokinetics of fleroxacin.
    Nightingale CH
    Am J Med; 1993 Mar; 94(3A):38S-43S. PubMed ID: 8452184
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Multiple-dose pharmacokinetics of ofloxacin, a new broad-spectrum antimicrobial agent.
    Dagrosa EE; Verho M; Malerczyk V; de Looze S; Hajdú P; Toyodera K
    Clin Ther; 1986; 8(6):632-45. PubMed ID: 3466701
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Renal handling of fleroxacin in rabbits, dogs, and humans.
    Shiba K; Saito A; Shimada J; Hori S; Kaji M; Miyahara T; Kusajima H; Kaneko S; Saito S; Ooie T
    Antimicrob Agents Chemother; 1990 Jan; 34(1):58-64. PubMed ID: 2109576
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacokinetics of fleroxacin after multiple oral dosing in patients receiving regular hemodialysis.
    Uehlinger DE; Schaedeli F; Kinzig M; Sörgel F; Frey FJ
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1903-9. PubMed ID: 8843301
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Influence of rifampin on fleroxacin pharmacokinetics.
    Schrenzel J; Dayer P; Leemann T; Weidekamm E; Portmann R; Lew DP
    Antimicrob Agents Chemother; 1993 Oct; 37(10):2132-8. PubMed ID: 8257135
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Influence of sex on the pharmacokinetic interaction of fleroxacin and ciprofloxacin with caffeine.
    Kim MK; Nightingale C; Nicolau D
    Clin Pharmacokinet; 2003; 42(11):985-96. PubMed ID: 12908854
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Single-dose pharmacokinetics of oral fleroxacin in bacteremic patients.
    Schrenzel J; Cerruti F; Herrmann M; Leemann T; Weidekamm E; Portmann R; Hirschel B; Lew DP
    Antimicrob Agents Chemother; 1994 Jun; 38(6):1219-24. PubMed ID: 8092817
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A comparison of the penetration of two quinolones into intra-abdominal abscess.
    Tudor RG; Youngs DJ; Yoshioka K; Burdon DW; Keighley MR
    Arch Surg; 1988 Dec; 123(12):1487-90. PubMed ID: 3142444
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High-performance liquid chromatographic determination of 6,8-difluoro-1-(2-fluoroethyl)-1,4- dihydro-7-(4-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid and its metabolites in laboratory animals.
    Kusajima H; Ooie T; Kawahara F; Uchida H
    J Chromatogr; 1986 Aug; 381(1):137-48. PubMed ID: 3095363
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Determination of the new fluoroquinolone fleroxacin and its N-demethyl and N-oxide metabolites in plasma and urine by high-performance liquid chromatography with fluorescence detection.
    Heizmann P; Dell D; Eggers H; Gora R
    J Chromatogr; 1990 Apr; 527(1):91-101. PubMed ID: 2114419
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Once-daily fleroxacin versus twice-daily ciprofloxacin in the treatment of complicated urinary tract infections.
    Frankenschmidt A; Naber KG; Bischoff W; Kullmann K
    J Urol; 1997 Oct; 158(4):1494-9. PubMed ID: 9302150
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vivo tissue pharmacokinetics by fluorine magnetic resonance spectroscopy: a study of liver and muscle disposition of fleroxacin in humans.
    Jynge P; Skjetne T; Gribbestad I; Kleinbloesem CH; Hoogkamer HF; Antonsen O; Krane J; Bakøy OE; Furuheim KM; Nilsen OG
    Clin Pharmacol Ther; 1990 Nov; 48(5):481-9. PubMed ID: 2121409
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacokinetics of quinolones in renal insufficiency.
    Fillastre JP; Leroy A; Moulin B; Dhib M; Borsa-Lebas F; Humbert G
    J Antimicrob Chemother; 1990 Oct; 26 Suppl B():51-60. PubMed ID: 2124213
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacokinetics of difloxacin in goats.
    Atef M; el-Banna HA; Abd El-Aty AM; Goudah A
    Dtsch Tierarztl Wochenschr; 2002 Jul; 109(7):320-3. PubMed ID: 12161971
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacokinetics of ciprofloxacin after intravenous and increasing oral doses.
    Bergan T; Thorsteinsson SB; Kolstad IM; Johnsen S
    Eur J Clin Microbiol; 1986 Apr; 5(2):187-92. PubMed ID: 2941278
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacokinetics of a new quinolone, AM-833, in mice, rats, rabbits, dogs, and monkeys.
    Kusajima H; Ishikawa N; Machida M; Uchida H; Irikura T
    Antimicrob Agents Chemother; 1986 Aug; 30(2):304-9. PubMed ID: 3094441
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A new trifluorinated quinolone: Ro 23-6240 (AM 833).
    Weidekamm E; Stöckel K; Dell D
    Drugs Exp Clin Res; 1987; 13(2):85-90. PubMed ID: 3107959
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Multiple-dose pharmacokinetics and tolerability of gemifloxacin administered orally to healthy volunteers.
    Allen A; Bygate E; Vousden M; Oliver S; Johnson M; Ward C; Cheon A; Choo YS; Kim I
    Antimicrob Agents Chemother; 2001 Feb; 45(2):540-5. PubMed ID: 11158752
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Possibility for induction of convulsion by fleroxacin and its disposition in the central nervous system in animals.
    Taga F; Kobayashi F; Saito S; Ooie T; Kawahara F; Uchida H; Shimada J; Hori S; Sakai O
    Arzneimittelforschung; 1990 Aug; 40(8):900-4. PubMed ID: 2173611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.